Efficient sequence of therapy for advanced and metastatic endometrial cancer
Historical standard of the first line endometrial cancer therapy was combination of paclitaxel and carboplatin.In more than a half of patients with advanced endometrial cancer receiving this combination, disease progression is observed after 2 years.Use of paclitaxel + carboplatin Incense combination in adjuvant therapy requires search for effectiv